A fluoroquinolone antibiotic
Related Products
Labeled Version(s)
34006Flumequine-13C3
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Flumequine

Item No. 21645

Technical Information
Formal Name
9-fluoro-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid
CAS Number
42835-25-6
Synonyms
  • (±)-Flumequine
  • R-802
Molecular Formula
C14H12FNO3
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 10 mg/mlDMSO: 10 mg/mlEthanol: 0.2 mg/ml
λmax
219, 230, 249, 325, 338 nm
SMILES
FC1=CC(CCC(C)N2C=C(C(O)=O)C3=O)=C2C3=C1
InChi Code
InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19)
InChi Key
DPSPPJIUMHPXMA-UHFFFAOYSA-N
Shipping & Storage Information
Storage
Room temperature
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Flumequine is a fluoroquinolone antibiotic.1 It is active against S. aureus, S. pyogenes, B. subtilis, E. coli, P. aeruginosa, S. faecalis, and K. pneumoniae (MICs = 1-100 µg/ml). Flumequine is also active against field isolates of B. hyodysenteriae (MICs = 6.25-200 µg/ml).2 It inhibits DNA gyrase, disrupting supercoiling of bacterial DNA to block transcription and replication.3 In vivo, flumequine (50 mg/kg) increases survival in rat models of P. vulgaris-induced urinary tract infection and P. mirabilis-induced prostatitis.1 Formulations containing flumequine have been used in the treatment of urinary tract infections in veterinary medicine.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Rohlfing, S.R., Gerster, J.R., and Kvam, D.C. Bioevaluation of the antibacterial flumequine for urinary tract use. Antimicrob. Agents Chemother. 10(1), 20-24 (1976).

    2. Aller-Morán, L.M., Martínez-Lobo, F.J., Rubio, P., et alEvaluation of the in vitro activity of flumequine against field isolates of Brachyspira hyodysenteriae. Res. Vet. Sci. 103, 51-53 (2015).

    3. Smith, J.T. The mode of action of 4-quinolones and possible mechanisms of resistance. J. Antimicrob. Chemother. 18 (Suppl. D), 21-29 (1986).